The new WHO classification of adrenal cortical proliferations reflects translational advances
in the fields of endocrine pathology, oncology and molecular biology. By adopting a …

Genetic predisposition for childhood cancer is under diagnosed. Identifying these patients
may lead to therapy adjustments in case of syndrome-related increased toxicity or resistant …

Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing
tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with …

Purpose Adrenocortical carcinoma (ACC) is an endocrine malignancy with a poor
prognosis. The association of adult-onset ACC with inherited cancer predisposition …

Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with limited
therapeutic options. The lack of mouse models that recapitulate the genetics of ACC has …

Adrenocortical carcinomas are rare tumours that can be diagnostically challenging.
Numerous multiparametric scoring systems and diagnostic algorithms have been proposed …

Adrenocortical cancer (ACC) is an orphan malignancy that results in heterogeneous clinical
phenotypes and molecular genotypes. There are no curative treatments for this deadly …

The concept of precursor lesions of endocrine neoplasms is a new and interesting topic in
endocrine pathology. A variety of clinicopathological conditions are associated with a …

Adrenocortical carcinoma (ACC) is a rare tumor with a poor prognosis. Most tumors are
either metastatic or locally invasive at the time of diagnosis. Differentiation between ACC …

Adrenocortical tumors (ACT) in children are very rare and are most frequently diagnosed in
the context of the Li-Fraumeni syndrome, a multiple cancer syndrome linked to germline …